Data for this review were identified by searches of PubMed with the terms “children”, “ependymoma”, “medulloblastoma”, “PNET”, and “posterior fossa”. Only papers published in English since 1990 were selected. Additional papers were identified from references of relevant articles and for historical value.
ReviewLate neurocognitive sequelae in survivors of brain tumours in childhood
Section snippets
Epidemiology and contemporary treatment
There are two recognised peaks in the incidence of brain tumours in children and adolescents (<18 years). The first peak, with a value of 2·2–2·5 cases per 100 000 children per year, occurs the first decade of life; there is a slight male predominance at this age. This first incidence peak accounts for most cases of CNS embryonal tumours and ependymomas located in the posterior fossa. A second, much larger peak occurs in late adolescence and early adulthood, and characteristically accounts for
Late effects of tumour and treatment
The most common method used to document neurocognitive effects in children treated for brain tumours has been IQ tests with a normative mean score of 100 and standard deviations of 15 or 16. IQ tests are standardised on large numbers of the general population, so scores can be corrected for the age of the person who is to complete the test. The IQ score of a healthy person is thus not expected to change substantially over time.Table 1 summarises findings from 12 studies of IQ outcomes in
Neurodevelopmental consequences
The pathophysiology of late CNS damage induced by radiation is not fully understood, especially with regard to the vulnerability of white matter to injury. Some hypotheses attribute primary mechanisms of CNS damage to the death of neuronal cells, oligodendrocytes, or endothelial cells and the subsequent microvascular damage. Ultimately, this damage seems to be a primary or secondary effect associated with administration of treatment to the CNS.25 Secondary processes, such as damage to the
Innovations in radiotherapy
The side-effects attributed to radiotherapy have been a main concern in the design of clinical trials for medulloblastoma during the past 20 years. Concern has been greatest for patients with average-risk medulloblastoma, for whom longterm control of disease is likely and the side-effects of therapy might be long-lasting. Radiotherapy for medulloblastoma is technically demanding, requiring both craniospinal radiotherapy and boost treatment of the anatomic posterior fossa. If the prescribed dose
Cognitive remediation
Few published studies have assessed cognitive behavioural interventions for survivors of brain tumours in childhood. One case study investigated whether a compensatory memory notebook would improve neurocognitive function in an adolescent with severe memory impairment.41 A calendar section was used to record forthcoming activities and events, and to keep track of time. The notebook had a section on things to do for forthcoming assignments; an orientation section contained the names of teachers
Pharmacotherapy
Research done over the past 50 years in children diagnosed with attention deficit hyperactivity disorder (ADHD) who are otherwise healthy has shown the effectiveness of stimulant medications—most commonly methylphenidate—to improve cognitive performance.44 Methylphenidate is a mixed dopaminergic–noradrenergic agonist that is thought to improve the function of the attention network in the frontostriatal region of the brain.45 Use of methylphenidate is found to have the most consistent and
Environmental interventions
In addition to cognitive remediation and pharmacological approaches to overcome neurocognitive deficits, the importance of ecological or environmentally based interventions for children with brain injuries—especially with regard to school—should not be underestimated.50 Many such children might need extended time limits for completion of school examinations, use of true-or-false questions and multiple-choice formats in tests rather than essay-based examinations, and encouragement to record
Conclusions
Neurosurgeons, paediatric oncologists, and radiation oncologists have been successful in improving cure rates for most types of childhood brain tumours, including those of the posterior fossa. Nevertheless, the risks of neurocognitive impairment remain substantial, especially among individuals who were treated aggressively and at a young age. Thus, there is an imperative need for effective, but less neurotoxic, tumour therapy. Until such therapy is developed, cognitive, behavioural,
Search strategy and selection criteria
References (52)
- et al.
Incidence of malignant tumours in US children
J Pediatr
(1975) - et al.
Preliminary results from a phase II trial of conformal radiation therapy for paediatric patients with localized low-grade astrocytoma and ependymoma
Int J Radiat Oncol Biol Phys
(2002) - et al.
Long-term intellectual outcome in children with posterior fossa tumours according to radiation doses and volumes
Int J Radiat Biol Phys
(1999) - et al.
A hybrid neural network analysis of subtle brain volume differences in children surviving brain tumours
Magn Reson Imaging
(1998) - et al.
Conformal radiotherapy,.reduced boost volume, hyperfractionnated radiotherapy and on-line quality control in standard risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol
Int J Radiat Oncol Biol Phys
(2003) - et al.
A multi-institution prospective trial of reduced-dose craniospinal irradiation (23·4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55·8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma
Int J Radiat Oncol Biol Phys
(2003) - et al.
Radiation dosevolume effects on growth hormone secretion
Int J Radiat Oncol Biol Phys
(2002) - et al.
Methylphenidate treatment
Pediatr Neurol
(2002) - et al.
The treatment and prognosis of medulloblastoma in children
AJR Am J Roentgenol
(1969) - et al.
Quality of life in long-term survivors of CNS tumours of childhood and adolescence
J Clin Oncol
(1991)